UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review

PloS one, 2011-02, Vol.6 (2), p.e17127

2011

Volltextzugriff (PDF)

Treatment of neuroblastoma with human natural antibodies

Autoimmunity reviews, 2008-06, Vol.7 (6), p.496-500

Erttmann, Rudolf

2008

Volltextzugriff (PDF)

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

The lancet oncology, 2005-09, Vol.6 (9), p.649-658

2005

Volltextzugriff (PDF)

Midkine is highly expressed in neuroblastoma tissues

Pediatric surgery international, 2008-12, Vol.24 (12), p.1355-1359

2008

Volltextzugriff (PDF)

Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival

Pediatric surgery international, 2008, Vol.24 (1), p.101-105

2008

Volltextzugriff (PDF)

Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial

JNCI cancer spectrum, 2021-08, Vol.5 (4)

2021

Volltextzugriff (PDF)

Comparison of Two Doses of Antithymocyte Globulin in Patients Undergoing Matched Unrelated Donor Allogeneic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2008-08, Vol.14 (8), p.913-919

2008

Volltextzugriff (PDF)

Ligands for the peroxisome proliferator-activated receptor-γ have inhibitory effects on growth of human neuroblastoma cells in vitro

Toxicology (Amsterdam), 2005-09, Vol.213 (1), p.157-168

2005

Volltextzugriff (PDF)

Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans

Nature medicine, 1996-06, Vol.2 (6), p.686-689

1996

Volltextzugriff (PDF)

Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors

Experimental hematology, 2008-08, Vol.36 (8), p.1047-1054

2008

Volltextzugriff (PDF)

Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen

Blood, 2009-11, Vol.114 (22), p.3393-3393

2009

Volltextzugriff (PDF)

Second Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Blood, 2008-11, Vol.112 (11), p.4308-4308

2008

Volltextzugriff (PDF)

Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG

Blood, 2008-11, Vol.112 (11), p.966-966

2008

Volltextzugriff (PDF)

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany

Cancer letters, 2003-07, Vol.197 (1), p.19-28

2003

Volltextzugriff (PDF)

Faster Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation of Younger Children Compared with Older Children and Adults

Blood, 2004-11, Vol.104 (11), p.1250-1250

2004

Volltextzugriff (PDF)

Lead-time and overdiagnosis estimation in neuroblastoma screening

Statistics in medicine, 2003-09, Vol.22 (18), p.2877-2892

2003

Volltextzugriff (PDF)

Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation

Journal of hematotherapy & stem cell research, 2003-04, Vol.12 (2), p.237-242

2003

Volltextzugriff (PDF)

Normal Human Serum Contains a Natural IgM Antibody Cytotoxic for Human Neuroblastoma Cells

Proceedings of the National Academy of Sciences - PNAS, 1996-04, Vol.93 (9), p.4498-4503

1996

Volltextzugriff (PDF)

Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma

Cancer chemotherapy and pharmacology, 1989, Vol.24 (6), p.376-380

1989

Volltextzugriff (PDF)

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany: Neuroblastoma - Developmental and molecular biology meet therapy design

Cancer letters, 2003, Vol.197 (1-2), p.19-28

2003

Volltextzugriff (PDF)

High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission

Clinical cancer research, 1997-12, Vol.3 (12), p.2671

1997

Volltextzugriff (PDF)

Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen

Cancer research (Chicago, Ill.), 1999-08, Vol.59 (15), p.3768-3775

1999

Volltextzugriff (PDF)

Reversal of multidrug resistance in friend leukemia cells by dexniguldipine-HCl

Cancer chemotherapy and pharmacology, 1993-01, Vol.32 (1), p.25-30

1993

Volltextzugriff (PDF)

Antimycotic Therapy with Liposomal Amphotericin-B for Patients Undergoing Bone Marrow or Peripheral Blood Stem Cell Transplantation

Leukemia & lymphoma, 1997-02, Vol.24 (5-6), p.491-499

1997

Volltextzugriff (PDF)

Pharmacokinetics of the 5HT3 Receptor Antagonist Tropisetron in Children

Pediatric hematology and oncology, 1996, Vol.13 (5), p.405-416

1996

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

KollektionWK Lippincott Williams & Wilkins–Connect here FIRST to enable access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(33)
Buchkapitel
(1)

Sprache

Englisch
(34)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review

Treatment of neuroblastoma with human natural antibodies

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

Midkine is highly expressed in neuroblastoma tissues

Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival

Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial

Comparison of Two Doses of Antithymocyte Globulin in Patients Undergoing Matched Unrelated Donor Allogeneic Stem Cell Transplantation

Ligands for the peroxisome proliferator-activated receptor-γ have inhibitory effects on growth of human neuroblastoma cells in vitro

Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans

Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors

Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen

Second Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany

Faster Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation of Younger Children Compared with Older Children and Adults

Lead-time and overdiagnosis estimation in neuroblastoma screening

Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation

Normal Human Serum Contains a Natural IgM Antibody Cytotoxic for Human Neuroblastoma Cells

Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany: Neuroblastoma - Developmental and molecular biology meet therapy design

High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission

Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen

Reversal of multidrug resistance in friend leukemia cells by dexniguldipine-HCl

Antimycotic Therapy with Liposomal Amphotericin-B for Patients Undergoing Bone Marrow or Peripheral Blood Stem Cell Transplantation

Pharmacokinetics of the 5HT3 Receptor Antagonist Tropisetron in Children

Aktive Filter

Suchergebnisse filtern